Phase I trial of adoptively transferred tumor-infiltrating lymphocyte immunotherapy following concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma.
Li J, Chen QY, He J, Li ZL, Tang XF, Chen SP, Xie CM, Li YQ, Huang LX, Ye SB, Ke M, Tang LQ, Liu H, Zhang L, Guo SS, Xia JC, Zhang XS, Zheng LM, Guo X, Qian CN, Mai HQ, Zeng YX.
Li J, et al. Among authors: tang lq, tang xf.
Oncoimmunology. 2015 Mar 6;4(2):e976507. doi: 10.4161/23723556.2014.976507. eCollection 2015 Feb.
Oncoimmunology. 2015.
PMID: 25949875
Free PMC article.